Donate Blood Give to Research
Careers Resources VersiPASS
Explore our service lines
Explore our service lines

The Science Behind a Second Chance

Learn how Dr. Brian Curtis and Versiti teams identified a rare CD36 antibody and found compatible platelets to support Semi after a bone marrow transplant.

The Science Behind a Second Chance

Milwaukee — September 11, 2026
 

Versiti researchers identify previously undetected antibodies linked to heparin-induced thrombocytopenia

Versiti researchers identified previously undetected antibodies linked to heparin-induced thrombocytopenia.The findings could guide more accurate diagnostic testing and improve patient safety.
Previous

RelatedInformation

 

Clinical Expertise

Connect with Versiti’s clinical experts in hematology, hematology genetics, transplantation, and transfusion medicine. Access specialized diagnostics, consultation, and insight that support complex patient care decisions across the continuum of blood health.
Learn More
 

Brian Curtis, PhD, D(ABMLI), MT(ASCP) SBB

Dr. Curtis is the senior director of diagnostic hematology and director of the Platelet & Neutrophil Immunology Lab.
Learn More
 

Semi and Temi Olumeko

After receiving a bone marrow transplant, Semi faced a rare complication that threatened his recovery. Versiti Blood Research Institute researchers found the answer, and his brother Temi provided the specially matched platelets he needed. Together, their story shows how family, blood donors and science can make hope possible.
Read Semi and Temi's Story
 

Versiti Blood Research Institute

Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.
Learn More